Publications To Date


    Filter Publications

    PAGE 1 OF 8 | DISPLAYING 1 - 15 OF 108 RESULTS

    Luo N. et al., DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer, 10.1038/s41467-017-02630-w, Nat. Commun., Jan 16, 2018

    Steggerda S.M. et al., Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment, 10.1186/s40425-017-0308-4, J. Immunother. Cancer, Dec 19, 2017

    Coelho M.A. et. al., Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA, 10.1016/j.immuni.2017.11.016, Immunity, Dec 19, 2017

    Zapka P. et al., Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms., 10.1093/jnen/nlx106, J. Neuropathol. Exp. Neurol., Dec 11, 2017

    Boldrini L. et al., Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma, 10.1186/s12935-017-0474-y, Cancer Cell Int., Nov 17, 2017

    Speir M. et al., Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins, 10.1038/s41598-017-14690-5, Sci. Reports, Oct 30, 2017

    Ghidini M. et al., Characterisation of the immune-related transcriptome in resected biliary tract cancers., 10.1016/j.ejca.2017.09.005, Eur. J. Cancer, Oct 05, 2017

    Sato-Kaneko F. et al., Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer, 10.1172/jci.insight.93397, JCI, Sep 21, 2017

    Ribas A. et al., Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy, , Cell, Sep 07, 2017

    Yeku O.O. et al., Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment, doi:10.1038/s41598-017-10940-8, Sci. Reports, Sep 05, 2017

    Poon E. et al., The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment, 10.1186/s40425-017-0268-8, J. Immunother. Can., Aug 15, 2017

    Yuan Y. et al., Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab, 10.1080/2162402X.2017.1363138, OncoImmunology, Aug 11, 2017

    Ren R. et al., Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance, 10.18632/oncotarget.20237 , Oncotarget, Aug 09, 2017

    Xu C. et al., Combination therapy with NHS-muIL12 and avelumab (anti-PD-L1) enhances antitumor efficacy in preclinical cancer models., 2017 Jul 5. pii: clincanres.0483.2017. doi: 10.1158/1078-0432.CCR-17-0483. [Epub ahead of print], Clin. Can. Res., Aug 04, 2017

    Kallert S.M. et al., Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy, 2017 May 26. doi: 10.1038/ncomms15327, Nature Commun., Aug 04, 2017